Keay Nakae's Stock Ratings

Chardan Capital Analyst

Keay Nakae is an analyst at Chardan Capital. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 11/15/2024

Overall Average Return

17.8%

Smart Score

67.1%

Overall Average Return Percentile

73rd

Number of Ratings

236
Data brought to you by Benzinga APIs

Recent Analyst Stock Rating News

Assessing Avidity Biosciences: Insights From 10 Financial Analysts
Alnylam Pharmaceuticals Stock: A Deep Dive Into Analyst Perspectives (24 Ratings)
Deep Dive Into Alnylam Pharmaceuticals Stock: Analyst Perspectives (24 Ratings)
In-Depth Examination Of 10 Analyst Recommendations For Avidity Biosciences
Evaluating Avidity Biosciences: Insights From 10 Financial Analysts
Unveiling 7 Analyst Insights On Avidity Biosciences
Femasys Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
Deep Dive Into Avidity Biosciences Stock: Analyst Perspectives (10 Ratings)
Analyst Expectations For Silence Therapeutics's Future
A Glimpse Into The Expert Outlook On Omega Therapeutics Through 4 Analysts
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

Ā© 2024 Benzinga | All Rights Reserved